Scientech Research LLC Acadia Pharmaceuticals Inc Transaction History
Scientech Research LLC
- $353 Billion
- Q4 2024
A detailed history of Scientech Research LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Scientech Research LLC holds 10,401 shares of ACAD stock, worth $150,086. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,401Holding current value
$150,086% of portfolio
0.05%Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
330Shares Held
167MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$619 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$174 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$126 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$105 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.34B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...